Manuel Mendizabal

Summary

Affiliation: Universidad Austral
Country: Argentina

Publications

  1. ncbi Noncirrhotic portal hypertension: another cause of liver disease in HIV patients
    Manuel Mendizabal
    Department of Gastroenterology, University of Pennsylvania, Philadelphia, USA
    Ann Hepatol 8:390-5. 2009
  2. ncbi Liver transplantation in patients with cystic fibrosis: analysis of United Network for Organ Sharing data
    Manuel Mendizabal
    Unidad de Hígado y Trasplante Hepático, Hospital Universitario Austral, Pilar, Argentina
    Liver Transpl 17:243-50. 2011
  3. ncbi Current management of hepatocellular carcinoma
    Manuel Mendizabal
    Servicio de Hepatologia, Trasplante Hepático y Cirugía Hepatobiliar, Hospital Universitario Austral, Pilar, Argentina
    Med Clin North Am 93:885-900, viii. 2009

Detail Information

Publications3

  1. ncbi Noncirrhotic portal hypertension: another cause of liver disease in HIV patients
    Manuel Mendizabal
    Department of Gastroenterology, University of Pennsylvania, Philadelphia, USA
    Ann Hepatol 8:390-5. 2009
    ..Prolonged exposure to ART, specially ddl, can play a pathogenic role. Rarely, liver synthetic function is sufficiently severe to warrant liver transplantation...
  2. ncbi Liver transplantation in patients with cystic fibrosis: analysis of United Network for Organ Sharing data
    Manuel Mendizabal
    Unidad de Hígado y Trasplante Hepático, Hospital Universitario Austral, Pilar, Argentina
    Liver Transpl 17:243-50. 2011
    ..Despite such observations, a survival benefit was noted in transplant patients versus those who remained on the waiting list...
  3. ncbi Current management of hepatocellular carcinoma
    Manuel Mendizabal
    Servicio de Hepatologia, Trasplante Hepático y Cirugía Hepatobiliar, Hospital Universitario Austral, Pilar, Argentina
    Med Clin North Am 93:885-900, viii. 2009
    ..A multikinase inhibitor, sorafenib, is the first molecular targeted oral therapy that has recently been shown to provide a survival benefit in HCC in select patients...